Table 3. Comparison of cross-reactivity of insulin analogs in various insulin assays.

System	Lumipulse G1200 (Fujirebio Inc., Tokyo, Japan)	Roche E170 (Roche Diagnostics, Mannheim, Germany)	Architect (Abbott Laboratories, IL, USA)	Immulite 2000 (Siemens Healthcare Diagnostics, NY, USA)	Unicel DxI Access (Beckman Coulter, CA, USA)	Advia Centaur (Siemens Healthcare Diagnostics, NY, USA)	Cisbio International (Schering, MA, USA)	IMx (Abbott Park, IL, USA)	Coat-A-Count (Siemens Healthcare Diagnostics, NY, USA)	E-test TOSOH II (Tosoh Co., Tokyo, Japan)
Humulin	+	+	+	+	+	+	+	+	+	+
Insulin aspart	−	−	+	+	+	+	+	+	+	+
Insulin lispro	−	−	+	+	+	+	+	+	+	+
Insulin glulisine	−	−	±	−	+	−	−	Not available	Not available	Not available
Insulin detemir	−	−	+	−	+	+	+	Not available	Not available	Not available
Insulin glargine	±	±	+	+	+	+	+	+	+	±
Reference	This study, 13	10,11,14,24,25,29,33	14,25,31,33	10,11,14,24,25,33	14,24,32,33	10,11,14,24,25,33	14	11,14,36	14,24	31